Insider trades › Merck › Richard R. DeLuca
Richard R. DeLuca: Merck stock transactions
Richard R. DeLuca (EVP&Pres, Merck Animal Heallth at Merck) reported 8 transactions in MRK stock on SEC Form 4 over the last 120 days. Name as filed with the SEC: DeLuca Richard R..
$6.7Mopen-market sales (51,370 shares)
$0open-market purchases (0 shares)
2026-08-12most recent transaction
Transactions
| Date | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|
| Aug 12, 2026 | Open-market sale | 11,099 | $131.61 | $1.5M | Form 4 ↗ |
| Aug 12, 2026 | Open-market sale | 600 | $132.04 | $79K | Form 4 ↗ |
| Aug 11, 2026 | Open-market sale | 7,410 | $131.33 | $973K | Form 4 ↗ |
| Aug 11, 2026 | Open-market sale | 5,427 | $132.35 | $718K | Form 4 ↗ |
| Aug 10, 2026 | Open-market sale | 20,784 | $130.43 | $2.7M | Form 4 ↗ |
| Aug 6, 2026 | Open-market sale | 805 | $131.02 | $105K | Form 4 ↗ |
| Aug 6, 2026 | Open-market sale | 4,945 | $130.23 | $644K | Form 4 ↗ |
| Aug 6, 2026 | Open-market sale | 300 | $131.02 | $39K | Form 4 ↗ |
Source: SEC EDGAR Form 4 filings; each row links to the filing. Sales marked "10b5-1 plan" were reported as made under a pre-arranged trading plan. Insider trades are reported facts, not recommendations. Not investment advice.